Syros Garners $30,000,000 Series A Financing

  • Feed Type
  • Date
    4/12/2013
  • Company Name
    Syros
  • Mailing Address
    480 Arsenal Street Watertown, MA 02472
  • Company Description
    Syros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. Syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data–a proficiency that is not well represented in pharmaceutical R&D.
  • Website
    http://www.syros.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    WuXi PharmaTech
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.